Stay updated with breaking news from Rotating Boulder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RNAimmune Inc., a biopharmaceutical company in Gaithersburg specializing in discovery and development of mRNA-based therapeutics and vaccines, announced Wednesday it has secured $27 million in a Series A round of financing. The company intends to use the funding to accelerate its research and development of mRNA vaccine and drug discovery focused on infectious disease, cancer, and ...
/PRNewswire/ -- RNAimmune, Inc. (the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based...
/PRNewswire/ -- The SparX Group of Cayman Island recently announced the closing of a B-round fund-raising of over 30 million USD. Co-founded by Dr. Gui-Dong...
/PRNewswire/ -- The SparX Group of Cayman Island recently announced the closing of a B-round fund-raising of over 30 million USD. Co-founded by Dr. Gui-Dong...
Press release content from PR Newswire. The AP news staff was not involved in its creation.